{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:33:42Z","timestamp":1786984422851,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000264","name":"Canadian Liver Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.aohep.2024.101576","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T17:58:12Z","timestamp":1726595892000},"page":"101576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epidemiology and natural history of chronic Hepatitis B in the Canadian province of Alberta from 2012 to 2021: A population-based study"],"prefix":"10.1016","volume":"30","author":[{"given":"Golasa Samadi","family":"Kochaksaraei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia H.","family":"Seow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-8378","authenticated-orcid":false,"given":"Herman W","family":"Barkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla S","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2940-897X","authenticated-orcid":false,"given":"Abdel-Aziz","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2024.101576_bib0001","unstructured":"World Health Organization. Hepatitis B. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b. [Published June 24, 2022]."},{"issue":"4","key":"10.1016\/j.aohep.2024.101576_bib0002","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update onprevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.aohep.2024.101576_bib0003","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"Clinical practice guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101576_bib0004","doi-asserted-by":"crossref","first-page":"E610","DOI":"10.9778\/cmajo.20190103","article-title":"Epidemiologic and clinical features of chronic hepatitis B virus infection in 8 Canadian provinces: a descriptive study by the Canadian HBV Network","volume":"7","author":"Coffin","year":"2019","journal-title":"CMAJ Open"},{"key":"10.1016\/j.aohep.2024.101576_bib0005","article-title":"Liver disease in Canada: A crisis in the making-An assessment of liver disease in Canada","author":"Sherman","year":"2013","journal-title":"Canadian Liver Foundation"},{"key":"10.1016\/j.aohep.2024.101576_bib0006","unstructured":"Action Hepatitis Canada. Progress toward viral hepatitis elimination in Canada: 2023Report. Toronto, ON. May 2023. https:\/\/www.actionhepatitiscanada.ca\/progressreport (Accessed May 2023)."},{"key":"10.1016\/j.aohep.2024.101576_bib0007","unstructured":"Government of Canada. Public Health Agency of Canada. Report on hepatitis B and C surveillance in Canada: 2019.https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/documents\/services\/publications\/diseases-conditions\/report-hepatitis-b-c-canada-2019\/report-hepatitis-b-c-canada-2019.pdf. [Published 17 January, 2022 ]."},{"issue":"9","key":"10.1016\/j.aohep.2024.101576_bib0008","doi-asserted-by":"crossref","first-page":"e44103","DOI":"10.1371\/journal.pone.0044103","article-title":"The impact of infection on population health: results of the Ontario burden of infectious diseases study","volume":"7","author":"Kwong","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.aohep.2024.101576_bib0009","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/apt.15803","article-title":"Mortality in adults with chronic hepatitis B infection in the United States: a population-based study","volume":"52","author":"Zhou","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.aohep.2024.101576_bib0010","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/cid\/ciy598","article-title":"Mortality among patients with chronic hepatitis b infection: the chronic hepatitis cohort study (CHeCS)","volume":"68","author":"Bixler","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.aohep.2024.101576_bib0011","unstructured":"Alberta Health Services. Data repository for reporting (AHSDRR) and data stores data asset inventory. https:\/\/nactrc.ca\/wp-content\/uploads\/2017\/04\/AHS-Data-Asset-Inventory.pdf. [Last updated December 2016]."},{"key":"10.1016\/j.aohep.2024.101576_bib0013","unstructured":"Statistics Canada. Population estimates on July 1st, by age and sex. https:\/\/doi.org\/10.25318\/1710000501-eng. [Date modified August 04, 2022 ]."},{"issue":"7","key":"10.1016\/j.aohep.2024.101576_bib0014","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00535-014-1011-6","article-title":"Long-term prognosis of patients with hepatitis B infection: causes of death and utility of nucleos(t)ide analogue therapy","volume":"50","author":"Tada","year":"2015","journal-title":"J Gastroenterol"},{"issue":"6","key":"10.1016\/j.aohep.2024.101576_bib0015","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jhep.2018.01.031","article-title":"Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population","volume":"68","author":"Papatheodoridis","year":"2018","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.aohep.2024.101576_bib0016","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.14309\/ajg.0000000000002074","article-title":"Comparable mortality between asian patients with chronic hepatitis b under long-term antiviral therapy vs matched control: a population-based study","volume":"118","author":"Yun","year":"2023","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.aohep.2024.101576_bib0017","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.14309\/ajg.0000000000000651","article-title":"Prevalence of chronic hepatitis B virus infection in the United States","volume":"115","author":"Lim","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.aohep.2024.101576_bib0018","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/hep.31782","article-title":"An updated assessment of chronic hepatitis B prevalence among foreign-born persons living in the United States","volume":"74","author":"Wong","year":"2021","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.aohep.2024.101576_bib0019","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3748\/wjg.v24.i11.1216","article-title":"Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia","volume":"24","author":"Binka","year":"2018","journal-title":"Canada. World J Gastroenterol"},{"key":"10.1016\/j.aohep.2024.101576_bib0020","article-title":"Hepatitis B. In: ECDC. Annual epidemiological report for 2020","year":"2022","journal-title":"Stockholm: ECDC"},{"key":"10.1016\/j.aohep.2024.101576_bib0021","unstructured":"Centers for Disease Control and Prevention. Hepatitis B surveillance 2020.https:\/\/www.cdc.gov\/hepatitis\/statistics\/2020surveillance\/hepatitis-b.htm#:\u223c:text=During. [Last reviewed August 19, 2022]."},{"issue":"2","key":"10.1016\/j.aohep.2024.101576_bib0022","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.24804","article-title":"Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin","volume":"56","author":"Kowdley","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2024.101576_bib0023","unstructured":"Canadian Institute for Health Information. Impact of Covid-19 on Canada's healthcare systems. https:\/\/www.cihi.ca\/en\/covid-19-resources\/impact-of-covid-19-on-canadas-health-care-systems. [Published February 24, 2022]."},{"key":"10.1016\/j.aohep.2024.101576_bib0025","unstructured":"Government of Alberta. Annual population report 2020-2021. chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/ https:\/\/open.alberta.ca\/dataset\/1050cf0a-8c1d-4875-9800-b7d2f3199e41\/resource\/608764dd-e247-4fc4-a99d-cbc59fc78a0c\/download\/2020-21-population-report.pdf. [Published September 29, 2021]."},{"key":"10.1016\/j.aohep.2024.101576_bib0026","unstructured":"Statistics Canada. Estimates of the components of international migration, quarterly. https:\/\/doi.org\/10.25318\/1710004001-eng. [Modified January 22, 2023]."},{"issue":"1","key":"10.1016\/j.aohep.2024.101576_bib0027","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.aohep.2024.101576_bib0028","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/j.1440-1746.2012.07167.x","article-title":"Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents","volume":"27","author":"Kim","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.aohep.2024.101576_bib0029","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.27723","article-title":"Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis","volume":"61","author":"Jang","year":"2015","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.aohep.2024.101576_bib0030","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/apt.13774","article-title":"Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients","volume":"44","author":"Lin","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.aohep.2024.101576_bib0031","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/hep.29320","article-title":"The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B","volume":"66","author":"Papatheodoridis","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.aohep.2024.101576_bib0032","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/apt.17158","article-title":"Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world","volume":"56","author":"Henry","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.aohep.2024.101576_bib0033","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2015.01.020","article-title":"Causes of death in people with chronic HBV infection: a population-based cohort study","volume":"62","author":"Montuclard","year":"2015","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.aohep.2024.101576_bib0034","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2893.2008.00982.x","article-title":"Cause of death in individuals with chronic HBV and\/or HCV infection, a nationwide community-based register study","volume":"15","author":"Duberg","year":"2008","journal-title":"J Viral Hepat"},{"issue":"5","key":"10.1016\/j.aohep.2024.101576_bib0035","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.cgh.2018.10.012","article-title":"Poor adherence to guidelines for treatment of chronic hepatitis B virus infection at primary care and referral practices","volume":"17","author":"Nguyen","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2024.101576_bib0036","doi-asserted-by":"crossref","first-page":"E431","DOI":"10.9778\/cmajo.20170002","article-title":"Hepatitis B virus testing and linkage to care in a Canadian urban tertiary referral centre: a retrospective cohort study","volume":"5","author":"Lau","year":"2017","journal-title":"CMAJ Open"},{"issue":"3","key":"10.1016\/j.aohep.2024.101576_bib0037","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3138\/canlivj.2019-0024","article-title":"Baseline assessment of and linkage to care for newly diagnosed patients with chronic hepatitis B","volume":"3","author":"Remington","year":"2019","journal-title":"Can. Liver J"},{"issue":"3","key":"10.1016\/j.aohep.2024.101576_bib0038","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/hep.32162","article-title":"The viral hepatitis B care cascade: a population-based comparison of immigrant groups","volume":"75","author":"Yasseen","year":"2022","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.aohep.2024.101576_bib0039","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/hep.26385","article-title":"Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles","volume":"58","author":"Lee","year":"2013","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.aohep.2024.101576_bib0040","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/ajg.2009.187","article-title":"Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus","volume":"104","author":"Chu","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aohep.2024.101576_bib0041","unstructured":"Health Canada. Canadian Alcohol and Drugs Survey (CADS): summary of results for 2019. https:\/\/www.canada.ca\/en\/health-canada\/services\/canadian-alcohol-drugs-survey\/2019-summary.html#a4. [Modified December 20, 2021]."}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124003594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124003594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:34:40Z","timestamp":1777782880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268124003594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1665268124003594"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101576","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and natural history of chronic Hepatitis B in the Canadian province of Alberta from 2012 to 2021: A population-based study","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101576","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101576"}}